Recent studies have shown that tumour cells can assume characteristics similar to those of immune-privileged tissues such as the low expression or absence of surface Fas receptor (Fas) and the expression of Fas ligand (FasL) (Hahne et al, 1996; Nagata, 1996; O'Connell et al, 2001). This evidence concerns the gene FAS and neoplasm.